- NGR-hTNF Vascular Targeting Agent Oncolytic
[作者:Vasitiou, S; Suria, R,期刊:Drugs of the Future, 页码:281-285 , 文章类型: Article,,卷期:2011年36-4]
- NGR-hTNF is a vascular targeting agent that consists of a modified form of human TNF-alpha fused with an NGR peptide. The NGR peptide moiety of the compound acts by selectively targeting blood vessels, where TNF is relea...
- NOVEL THERAPEUTIC APPROACHES FOR GLAUCOMA
[作者:Rasmussen, CA; Kaufman, PL,期刊:Drugs of the Future, 页码:287-300 , 文章类型: Review,,卷期:2011年36-4]
- Glaucoma refers to a collection of progressive optic neuropathies that can lead to irreversible damage to retinal ganglion cells and their axons, and eventual loss of vision if left untreated or treated unsuccessfully. T...
|